Source: Wikipedia, the free encyclopedia.
Pharmaceutical drug classification
ATC code L Antineoplastic and immunomodulating agents is a section of the
Codes for
ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,
QL.
[5] National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
antineoplastic agents ( L01)
|
---|
CI monoclonal antibodies ("-mab") | |
---|
Tyrosine kinase inhibitors ("-nib") | Receptor tyrosine kinase |
- RET inhibitors: Entrectinib (ALK, ROS1, NTRK), Futibatinib (FGFR2), Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Vandetanib (VEGFR, EGFR).
|
---|
Non-receptor | |
---|
|
---|
Other | |
---|
|
---|
Intracellular (initiation) | |
---|
Intracellular (reception) | IL-1 receptor antagonists | |
---|
mTOR | |
---|
|
---|
Extracellular | |
---|
Unsorted | |
---|